Both in Pharmaceuticals
PTC Therapeutics vs Ligand Pharmaceuticals
Over the past year PTCT returned +0.3% and LGND returned +63.9%; their daily moves had a correlation of 0.33.
PTCT +0.3% LGND +63.9%Growth of $1, one year, split-adjusted
| Metric | PTCT | LGND |
|---|---|---|
| Price | $68.12 | $313.52 |
| Market cap | $5.69B | $6.27B |
| Today | +11.89% | +2.12% |
| 1 month | +7.0% | +2.2% |
| 6 months | +4.7% | +35.0% |
| Year to date | −10.3% | +65.8% |
| 1 year | −0.3% | +63.9% |
| Revenue growth (YoY) | +69.6% | −31.8% |
| Gross margin | 93.4% | 83.7% |
| Net margin | −14.4% | −36.2% |
| P/E (TTM) | — | 121.9× |
| Price / sales | 4.9× | 24.7× |
| Net cash | $1.59B | -$653.3M |
| Dividend yield | — | — |
| Volatility (60d) | 43.4% | 29.7% |
| Short % of float | 10.5% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).